5:38 PM
 | 
Jun 17, 2013
 |  BC Extra  |  Financial News

Repros, Exact Sciences planning follow-ons

Repros Therapeutics Inc. (NASDAQ:RPRX) and Exact Sciences Corp. (NASDAQ:EXAS) both announced plans late Monday to raise money in follow-ons. Repros proposed to sell up to 3 million shares in a follow-on underwritten by BofA Merrill Lynch;...

Read the full 169 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >